Strikes disrupt hundreds of flights at 13 airports in Germany
A one-day strike by workers at 13 German airports, including the Frankfurt and Munich hubs and all the country's other main destinations, caused the cancelation of most flights on Monday.
The 24-hour walkout, which started at midnight, involves public-sector employees at the airports as well as ground and security staff.
At Frankfurt Airport, 1,054 of the day's 1,116 scheduled takeoffs and landings had been canceled, German news agency Deutsche Presse-Agentur reported, citing airport traffic management.
All of Berlin Airport's regular departures and arrivals were canceled, while Hamburg Airport said no departures would be possible. Cologne/Bonn Airport said there was no regular passenger service and Munich Airport advised travelers to expect a 'greatly reduced flight schedule.'
The Verdi service workers union's strike also targeted the Hamburg, Bremen, Hannover, Berlin, Duesseldorf, Dortmund, Cologne/Bonn, Leipzig/Halle, Stuttgart and Munich airports. At the smaller Weeze and Karlsruhe/Baden-Baden airports, only security workers were called out.
The union announced the strike on Friday. But at Hamburg Airport, it added a short-notice walkout on Sunday to the strike on Monday, arguing that it must ensure the measure was effective.
The so-called 'warning strike,' a common tactic in German wage negotiations, relates to two separate pay disputes: negotiations on a new pay and conditions contract for airport security workers, and a wider dispute over pay for employees of federal and municipal governments.
The latter already has led to walkouts at Cologne/Bonn, Duesseldorf, Hamburg and Munich airports. Pay talks in that dispute are due to resume on Friday, while the next round of talks for airport security workers is expected to start on March 26.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Russia using peace talks to stall US sanctions, Zelensky says
Russia is attempting to delay peace negotiations to avoid tougher U.S. sanctions, President Volodymyr Zelensky said in an interview with German tabloid Bild on June 12. His comments come as Russia continues to reject a full ceasefire despite having initiated two rounds of peace talks in Istanbul — first on May 16 and on June 2. Both rounds resulted in agreements on prisoner exchanges, but failed to deliver progress toward ending hostilities. During the negotiations, Moscow ramped up ground offensives and launched massive attacks on Ukrainian cities. "It's important for them to show (U.S. President Donald) Trump that there is a diplomatic bridge between Ukraine and Russia," Zelensky told Bild. "So that sanctions aren't imposed against Russia" while talks are ongoing, Zelensky said, adding that Russian President Vladimir Putin's strategy is to maintain the illusion of dialogue and then argue: "We're talking to each other! If sanctions are imposed, there will be no more talks." Zelensky warned that Moscow's goal is not peace but buying time. "Putin feels that his economy is now suffering," he said. "But he wants to gain even more time until the strong sanctions are introduced, because he can still hold out for some time." Trump has previously warned he would impose new sanctions on Moscow, but has yet to take the step. On June 5, Trump said he was withholding the move in hopes of a potential peace deal but warned he could act if Russia continues to stall. "When I see the moment where it's not going to stop... we'll be very tough," Trump told reporters. Critics, as well as Zelensky, argue that the slow implementation of sanctions gave Russia time to adapt its economy and defense sector. "The main mistake of the sanctions was that they were introduced too slowly," Zelensky said. Trump has repeatedly said he is monitoring the situation and hinted sanctions could come soon if progress is not made. Meanwhile, a bipartisan bill in the U.S. Senate that would impose harsh tariffs on countries buying Russian oil remains on hold as lawmakers await Trump's signal. Read also: 'Deadline is in my brain' — Trump dismisses timeline to impose Russian sanctions We've been working hard to bring you independent, locally-sourced news from Ukraine. Consider supporting the Kyiv Independent.
Yahoo
2 hours ago
- Yahoo
Outcomes4Me Acquires Germany's Mika Health App to Accelerate AI-Driven Patient Empowerment Globally
Mika's cancer app is a certified medical device clinically proven to help cancer patients cope with both the physical and psychological effects of their diagnosis BOSTON and BERLIN, June 12, 2025 /PRNewswire/ -- Outcomes4Me Inc., the developer of the leading, direct-to-patient, AI-driven platform transforming the cancer-care experience, announced today that its German affiliate Outcomes4Me Germany GmbH has acquired the assets associated with the Mika Health app from Berlin-based Fosanis GmbH. The Mika app has served over 100,000 cancer patients globally, and is a clinically validated platform proven in clinical trials to reduce a range of symptoms associated with cancer care including depression, anxiety, and fatigue. Outcomes4Me, which supports more than 280,000 cancer patients, recently finalized a $21M funding round, emphasizing the company's plans to expand both its patient community and commercial business globally. This acquisition strengthens Outcomes4Me's platform with Mika's proven interventions for real-time symptom management, behavioral coaching, and emotional support, setting a new global standard for digital oncology support. It also allows Outcomes4Me to scale faster in European markets, leveraging Mika's regulatory readiness as MDR IIa-certified medical device and local partnerships. "With this acquisition, we're taking a major step toward our mission to make cancer understandable and manageable to every patient wherever and whomever they are," said Maya Sc.D., Founder and CEO of Outcomes4Me. "Mika's proven AI-driven emotional support technology and European footprint complement our evidence-based platform grounded in clinical guidelines and U.S. footprint. Together, we're building the most comprehensive digital companion for cancer patients worldwide." "Joining forces with Outcomes4Me allows us to take our vision further, faster," said Gandolf Finke, Ph.D., Founder and Managing Director of Fosanis GmbH. "We're excited to integrate our technology with a partner that shares our values of transparency, trust, and patient empowerment. The overlap in our customer base of global pharmaceutical companies that prioritize innovation and whole-patient care creates many synergies and allows us to immediately deliver combined value for our patients and business partners alike. For our patients using Mika, this transaction has no impact in terms of service they can expect." Outcomes4Me will exhibit at HLTH Europe in Amsterdam from June 16-19, 2025. Visit Outcomes4Me and Mika in the AI Spotlight pavilion at booth #F70-2. About Outcomes4MeOutcomes4Me is the first and leading end-to-end, AI-driven patient empowerment platform that helps patients with cancer take a proactive approach to their care from diagnosis throughout every stage of life and care. Its direct-to-patient platform integrates clinical guidelines, genomics, trial matching, and symptom tracking to help patients navigate through a cancer diagnosis with confidence and clarity. Through its patented technology, Outcomes4Me is redefining cancer care by delivering smarter, AI-powered solutions that put patients in control of their treatment decisions. What sets Outcomes4Me apart is its ability to generate unique, at-scale proprietary datasets that enable more precise and actionable insights for better patient outcomes. Based in Boston, Massachusetts, Outcomes4Me is a woman-led company of seasoned healthcare, oncology, pharmaceutical, consumer and technology veterans. For more information, visit About Mika HealthMika Health is an app-based platform aimed at providing targeted and comprehensive support to people with cancer using digital technology. Through scientifically proven methods and techniques of therapy management, the Digital Therapeutics (DTx) helps patients to actively participate in their treatment and regain more quality of life - with daily symptom monitoring, psychologically oriented coaching courses, and AI-supported, personalized recommendations. To achieve this, Mika combines innovative machine learning technologies with a multimedia knowledge database of rigorously verified content, such as nutritional tips, exercise routines, or mindfulness training. For more information, visit View original content: SOURCE Outcomes4Me Inc.
Yahoo
5 hours ago
- Yahoo
Investing in LIMES Schlosskliniken (ETR:LIK) five years ago would have delivered you a 280% gain
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of LIMES Schlosskliniken AG (ETR:LIK) stock is up an impressive 280% over the last five years. It's also up 29% in about a month. Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During the five years of share price growth, LIMES Schlosskliniken moved from a loss to profitability. Sometimes, the start of profitability is a major inflection point that can signal fast earnings growth to come, which in turn justifies very strong share price gains. You can see below how EPS has changed over time (discover the exact values by clicking on the image). This free interactive report on LIMES Schlosskliniken's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. While the broader market gained around 19% in the last year, LIMES Schlosskliniken shareholders lost 0.6%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 31%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. Before forming an opinion on LIMES Schlosskliniken you might want to consider these 3 valuation metrics. For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on German exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
